Indications for use: short-term therapy for pain syndromes associated with rheumatic diseases (rheumatoid arthritis, osteoarthritis). Neuralgia, myalgia, lumbosciatica, post-traumatic pain syndrome with inflammation, postoperative pain, headache, migraine, dysmenorrhea, adnexitis, proctitis, toothache. As part of complex therapy for infectious and inflammatory diseases of the ear, throat, and nose with severe pain and fever (pharyngitis, tonsillitis, otitis).
Method of administration and dosage: taken orally, unchewed, during or after meals, with a small amount of water. Adults: 1 tablet 2-3 times a day. The duration of therapy is up to 7 days.
Contraindications: hypersensitivity (including to other NSAIDs), erosive and ulcerative lesions of the gastrointestinal tract (during exacerbation), gastrointestinal bleeding, history of bronchial obstruction attacks, rhinitis, urticaria after taking acetylsalicylic acid or other NSAIDs (complete or incomplete intolerance syndrome of acetylsalicylic acid – rhinosinusitis, urticaria, nasal polyps, bronchial asthma), post-coronary artery bypass surgery, inflammatory bowel diseases in the acute phase, severe hepatic insufficiency or active liver disease, severe renal insufficiency (creatinine clearance less than 30 ml/min), progressive kidney diseases, hematopoiesis disorders, hemostasis disorders (including hemophilia), pregnancy, childhood, lactation period.
Shelf life: 4 years.
Manufacturer: Nabros Pharma Pvt. Ltd., National Highway No. 8, Kajipura-387411, Kheda District, Gujarat, India.
